Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16429664 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TP53CYP3A4TSHRMAPK1 | |
| SCHEMBL353078 | 0.80 | — | — | |
| SCHEMBL7768851 | 0.77 | ALDH1A1 (0.71) | ALDH1A1TP53CYP3A4TSHRMGLL | |
| SCHEMBL14413803 | 0.77 | ALDH1A1 (0.66) | ALDH1A1TP53CYP3A4TSHRMAPK1 | |
| SCHEMBL11486118 | 0.75 | — | — | |
| SCHEMBL4653150 | 0.75 | ALDH1A1 (0.58) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL16403665 | 0.75 | ALDH1A1 (0.69) | ALDH1A1TP53CYP3A4TSHRMGLL | |
| SCHEMBL5802030 | 0.75 | ALDH1A1 (0.69) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL526633 | 0.74 | TSHR (0.54) | ALDH1A1TP53CYP3A4TSHRMAPK1 | |
| SCHEMBL543862 | 0.74 | ALDH1A1 (0.69) | ALDH1A1TP53CYP3A4TSHRMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4131549-B1 | CAPSULE FOR LITHIUM-SULFUR SECONDARY BATTERY, AND LITHIUM-SULFUR SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2026-05-13 | — | — | EP | claimed |
| EP-3900751-B1 | FILLER HAVING EXCELLENT FILLER PROPERTIES COMPRISING HYALURONIC ACID HYDROGEL | LG CHEMICAL LTD (KR) | 2025-08-20 | — | — | EP | claimed |
| US-12341162-B2 | Capsule for lithium-sulfur secondary battery, and lithium-sulfur secondary battery comprising same | LG ENERGY SOLUTION, LTD. (KR) | 2025-06-24 | — | — | US | claimed |
| US-12128154-B2 | Filler comprising hyaluronic acid hydrogel having excellent filling properties | LG CHEM, LTD. (KR) | 2024-10-29 | — | — | US | claimed |
| US-20240042095-A1 | COMPOSITION FOR TREATING WOUND COMPRISING DERMAL TISSUE-DERIVED EXTRACELLULAR MATRIX AND METHOD FOR PREPARING SAME | L&C BIO CO., LTD. (KR) | 2024-02-08 | — | — | US | claimed |
| US-20230344018-A1 | CAPSULE FOR LITHIUM-SULFUR SECONDARY BATTERY, AND LITHIUM-SULFUR SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2023-10-26 | — | — | US | claimed |
| EP-4261245-A1 | METHOD FOR PRODUCING HIGHLY SWELLABLE HYALURONIC ACID BEAD GEL | Yu Co., Ltd. (KR) | 2023-10-18 | — | — | EP | claimed |
| US-20230044236-A1 | Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same | L&C BIO CO., LTD. (KR) | 2023-02-09 | — | — | US | claimed |
| EP-4131549-A1 | CAPSULE FOR LITHIUM-SULFUR SECONDARY BATTERY, AND LITHIUM-SULFUR SECONDARY BATTERY COMPRISING SAME | LG Energy Solution, Ltd. (KR) | 2023-02-08 | — | — | EP | claimed |
| US-20220378980-A1 | COMPOSITE DEMINERALIZED BONE MATRIX COMPOSITION CONTAINING BONE MINERAL COMPONENT AND METHOD FOR PRODUCING SAME | L&C BIO CO., LTD. (KP) | 2022-12-01 | — | — | US | claimed |
| EP-2637710-A1 | HYALURONIC ACID BASED FORMULATIONS | Allergan Industrie, SAS (FR) | 2013-09-18 | — | — | EP | claimed |
| WO-2012062775-A1 | HYALURONIC ACID BASED FORMULATIONS | ALLERGAN INDUSTRIE, SAS (FR) | 2012-05-18 | — | — | WO | claimed |
| JP-2011529763-A | — | — | 2011-12-15 | — | — | JP | claimed |
| JP-2011529762-A | — | — | 2011-12-15 | — | — | JP | claimed |
| EP-2326302-A1 | HYALURONIC ACID-BASED GELS INCLUDING ANESTHETIC AGENTS | Allergan Industrie SAS (FR) | 2011-06-01 | — | — | EP | claimed |
| EP-2323617-A1 | HYALURONIC ACID-BASED GELS INCLUDING ANESTHETIC AGENTS | Allergan Industrie SAS (FR) | 2011-05-25 | — | — | EP | claimed |
| WO-2010015901-A1 | HYALURONIC ACID-BASED GELS INCLUDING ANESTHETIC AGENTS | ALLERGAN INDUSTRIE SAS (FR) | 2010-02-11 | — | — | WO | claimed |
| WO-2010015900-A1 | HYALURONIC ACID-BASED GELS INCLUDING ANESTHETIC AGENTS | ALLERGAN INDUSTRIE SAS (FR) | 2010-02-11 | — | — | WO | claimed |
| WO-2009073437-A1 | POLYSACCHARIDE GEL FORMULATION | ALLERGAN, INC. (US) | 2009-06-11 | — | — | WO | claimed |
| WO-2008034176-A1 | CROSS-LINKED POLYSACCHARIDE GELS | ULTRACEUTICALS R & D PTY LTD (AU) | 2008-03-27 | — | — | WO | claimed |